Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Interest Coverage Ratio (2021 - 2025)

Serina Therapeutics (SER) has disclosed Interest Coverage Ratio for 5 consecutive years, with 31.35 as the latest value for Q4 2025.

  • Quarterly Interest Coverage Ratio rose 90.4% to 31.35 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 112.78 through Dec 2025, down 247.97% year-over-year, with the annual reading at 112.78 for FY2025, 247.97% down from the prior year.
  • Interest Coverage Ratio hit 31.35 in Q4 2025 for Serina Therapeutics, up from 1065.33 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 1.37 in Q4 2023 to a low of 1065.33 in Q3 2025.
  • Historically, Interest Coverage Ratio has averaged 144.28 across 5 years, with a median of 11.19 in 2023.
  • Biggest five-year swings in Interest Coverage Ratio: soared 175.15% in 2023 and later tumbled 23937.54% in 2024.
  • Year by year, Interest Coverage Ratio stood at 6.33 in 2021, then soared by 71.21% to 1.82 in 2022, then skyrocketed by 175.15% to 1.37 in 2023, then crashed by 23937.54% to 326.41 in 2024, then surged by 90.4% to 31.35 in 2025.
  • Business Quant data shows Interest Coverage Ratio for SER at 31.35 in Q4 2025, 1065.33 in Q3 2025, and 618.33 in Q2 2025.